CL2011002302A1 - Uso de una composicion que comprende un monocaprina y un diluyente farmaceuticamente aceptable para el tratamiento de una condicion micotica causada por trichophyton rubrum tal como tinea pedis, tinea crusis, dermatofitosis y onicomicosis. - Google Patents

Uso de una composicion que comprende un monocaprina y un diluyente farmaceuticamente aceptable para el tratamiento de una condicion micotica causada por trichophyton rubrum tal como tinea pedis, tinea crusis, dermatofitosis y onicomicosis.

Info

Publication number
CL2011002302A1
CL2011002302A1 CL2011002302A CL2011002302A CL2011002302A1 CL 2011002302 A1 CL2011002302 A1 CL 2011002302A1 CL 2011002302 A CL2011002302 A CL 2011002302A CL 2011002302 A CL2011002302 A CL 2011002302A CL 2011002302 A1 CL2011002302 A1 CL 2011002302A1
Authority
CL
Chile
Prior art keywords
tinea
onychomycosis
treatment
crusis
monocaprine
Prior art date
Application number
CL2011002302A
Other languages
English (en)
Spanish (es)
Inventor
Jon Lenn
Barry Hunt
Hans Hofland
Edward Hsia
Original Assignee
Stiefel Res Australia Pty Ltd
Stiefel Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42740006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011002302(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Res Australia Pty Ltd, Stiefel Laboratories filed Critical Stiefel Res Australia Pty Ltd
Publication of CL2011002302A1 publication Critical patent/CL2011002302A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2011002302A 2009-03-20 2011-09-16 Uso de una composicion que comprende un monocaprina y un diluyente farmaceuticamente aceptable para el tratamiento de una condicion micotica causada por trichophyton rubrum tal como tinea pedis, tinea crusis, dermatofitosis y onicomicosis. CL2011002302A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20263509P 2009-03-20 2009-03-20
US21331309P 2009-05-28 2009-05-28

Publications (1)

Publication Number Publication Date
CL2011002302A1 true CL2011002302A1 (es) 2012-06-22

Family

ID=42740006

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011002302A CL2011002302A1 (es) 2009-03-20 2011-09-16 Uso de una composicion que comprende un monocaprina y un diluyente farmaceuticamente aceptable para el tratamiento de una condicion micotica causada por trichophyton rubrum tal como tinea pedis, tinea crusis, dermatofitosis y onicomicosis.

Country Status (15)

Country Link
US (2) US20110305646A1 (enExample)
EP (1) EP2408299B1 (enExample)
JP (1) JP5992324B2 (enExample)
KR (1) KR101506369B1 (enExample)
CN (1) CN102368904B (enExample)
AU (1) AU2010226476B2 (enExample)
BR (1) BRPI1014529A2 (enExample)
CA (1) CA2756047C (enExample)
CL (1) CL2011002302A1 (enExample)
EA (1) EA022569B1 (enExample)
ES (1) ES2437395T3 (enExample)
IL (1) IL214887A (enExample)
MX (1) MX2011009781A (enExample)
PL (1) PL2408299T3 (enExample)
WO (1) WO2010108060A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010254064B2 (en) * 2009-05-29 2015-01-22 Palau Pharma, S.L.U Azole antifungal compositions
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
JP6125718B2 (ja) * 2014-03-26 2017-05-10 株式会社マンダム デオドラント組成物及びデオドラント剤
CN104672506A (zh) * 2015-02-02 2015-06-03 安徽玉堂雨具有限公司 一种抗菌防霉生物降解塑料及其制备方法
KR20190037229A (ko) * 2016-06-13 2019-04-05 바이옴 테라퓨틱스 리미티드 상승효과적 항진균 조성물 및 그의 방법
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
KR20220118492A (ko) * 2019-12-20 2022-08-25 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 조갑진균증을 치료하기 위한 국소 제약 조성물
KR102442047B1 (ko) * 2020-09-10 2022-09-08 서울대학교산학협력단 설페이트와 아민기를 함유하는 지방산 글리세리드 화합물, 이의 생산 방법, 및 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
FI912955A7 (fi) * 1990-06-25 1991-12-26 Res Foundation For Mental Hygiene Antimikrobiset rasvahappokoostumukset
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
RU2122402C1 (ru) * 1995-07-18 1998-11-27 Научно-производственная фирма "Фаркос" Товарищество с ограниченной ответственностью Средство для лечения и профилактики грибковых заболеваний кожи на основе гризеофульвина
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
JP2005503318A (ja) * 2000-02-16 2005-02-03 ベントレー ファーマシューティカルズ インコーポレイテッド 医薬組成物
JP2004043336A (ja) * 2002-07-10 2004-02-12 Naris Cosmetics Co Ltd 抗菌剤及びそれを配合してなる化粧料
AU2003246697A1 (en) * 2002-07-22 2004-02-09 Ciba Specialty Chemicals Holding Inc. Copolymers and their use in personal care compositions
US20050165104A1 (en) * 2002-07-24 2005-07-28 Holwerda James G. Biocidal agents and veterinary methods
EP1633818A2 (en) * 2003-04-18 2006-03-15 MERCK PATENT GmbH Antimicrobial pigments
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US8796332B2 (en) * 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
RU2337689C1 (ru) * 2007-04-18 2008-11-10 Общество с ограниченной ответственностью "Фармацевтические технологии" Средство для лечения поверхностных микозов
US8226965B2 (en) * 2008-04-25 2012-07-24 Nanobio Corporation Methods of treating fungal, yeast and mold infections

Also Published As

Publication number Publication date
MX2011009781A (es) 2011-10-17
EP2408299A4 (en) 2012-08-15
EP2408299A1 (en) 2012-01-25
BRPI1014529A2 (pt) 2015-08-25
EP2408299B1 (en) 2013-10-23
KR101506369B1 (ko) 2015-03-30
CA2756047C (en) 2016-04-26
JP5992324B2 (ja) 2016-09-14
WO2010108060A8 (en) 2011-12-29
AU2010226476B2 (en) 2013-02-07
IL214887A0 (en) 2011-11-30
PL2408299T3 (pl) 2014-03-31
US20180360791A1 (en) 2018-12-20
CA2756047A1 (en) 2010-09-23
ES2437395T3 (es) 2014-01-10
EA022569B1 (ru) 2016-01-29
US20110305646A1 (en) 2011-12-15
EA201171150A1 (ru) 2012-03-30
KR20120014553A (ko) 2012-02-17
CN102368904A (zh) 2012-03-07
IL214887A (en) 2015-09-24
AU2010226476A1 (en) 2011-09-22
WO2010108060A1 (en) 2010-09-23
CN102368904B (zh) 2014-03-26
JP2012521351A (ja) 2012-09-13

Similar Documents

Publication Publication Date Title
CO2018001375A2 (es) Composiciones de retinoides tópicos
PE20140255A1 (es) Tableta dispersable en forma oral
MX2019001253A (es) Conjugados de proteina-agente activo y metodo para su preparacion.
CL2011002648A1 (es) Composicion topica que comprende un compuesto derivado de 1,2,4-tiadiazol o tiourea, un agente modificador de la viscosidad, un conservante y agua; estuche para la composicion; metodo para preparar la composicion; y uso para tratar una enfermedad o trastorno dermatologico mediado por un receptor de melanocortina tal como acne.
CL2011002053A1 (es) Composicion farmaceutica de espuma en aerosol en emulsion de aceite en agua que comprende un agente farmaceuticamente activo, agua, aceite, disolvente organico, componente tensoactivo, y propulsor; procedimiento de preparacion; uso para tratar enfermedades, o afecciones de la piel.
GT201200024A (es) Formulación subcutánea de anticuerpo anti-her2
AR089578A1 (es) Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion
UY33598A (es) Imidazopiridazinas sustituidas
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
CO6511229A2 (es) Metodos para reducir la actividad viricida en composiciones pcv-2 y composiciones pcv-2 con una inmunogeicidad mejorada
PE20121709A1 (es) Una composicion farmaceutica para tratar cancer que comprende tripsinogeno y/o quimotripsinogeno y un agente activo seleccionado a partir de un compuesto de selenio, un compuesto vainilloide y un agente reductor de glicolisis citoplasmica
MX2012005013A (es) Pterostilbeno (peter) para su uso en la prevencion y/el tratamiento de enfermedades, daños o lesiones de la piel.
MX2011012143A (es) Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas.
MX2011011058A (es) Antagonistas del receptor ep4 para el tratamiento de cancer.
MX2015011316A (es) Imidazopiridazinas sustituidas.
PE20121467A1 (es) Formulacion de aerosol para la enfermedad pulmonar obstructiva cronica
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
MX2015012273A (es) Composicion farmaceutica para el tratamiento de infecciones micoticas.
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
MX2014012742A (es) Composicion para el tratamiento de transtornos metabólicos.
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
DOP2016000007A (es) Pirazolpiridinas sustituidas
AR087790A1 (es) Uso de un inhibidor de aromatasa para el tratamiento de hipogonadismo y enfermedades relacionadas
AR087075A1 (es) Composiciones para el cuidado personal, un compuesto activo
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta